Human adenovirus 4 is an unenveloped, double‑stranded DNA virus classified within species E of the genus Mastadenovirus. Its virion contains an icosahedral capsid about 70–90 nm in diameter with fibre proteins projecting from each vertex and a linear genome tethered to terminal proteins. Type 4 is one of the prototype strains associated with acute respiratory disease outbreaks, particularly among military recruits.
Biology and pathogenesis
Adenoviruses number more than a hundred types divided into species A through G. HAdV‑4 belongs to species E and displays a strong tropism for the respiratory epithelium. After inhalation of infectious droplets, the virus binds to cellular receptors and is internalised. Replication occurs in the nucleus, producing progeny virions that lyse the host cell. Latent infection may persist in lymphoid tissue such as the tonsils or adenoids. Host immunity involves neutralising antibodies and cytotoxic T‑cell responses, but herd immunity wanes in populations with little exposure, allowing epidemics.
Clinical features and notable facts
HAdV‑4 is a well‑recognised cause of acute respiratory disease in crowded settings. In contrast to types that primarily cause conjunctivitis or gastroenteritis, type 4 typically produces febrile pharyngitis, cough, headache and sometimes pneumonia. Outbreaks have been documented in military training camps, leading to development of a live oral vaccine targeting types 4 and 7; this vaccine significantly reduced illness among recruits. Type 4 may also cause sporadic pharyngoconjunctival fever in civilian populations, but severe disease is uncommon compared with type 14 or type 7. In most cases, infection with human adenovirus 4 is self‑limited and confers long‑lasting immunity. Awareness of its association with military outbreaks highlights the importance of vaccination and surveillance in high‑risk environments. Related Terms: Human Adenovirus 7, Human Adenovirus 14, Acute respiratory disease, Adenovirus vaccine